November 2012 Issue of MMM
November 2012 MM&M
When toilet paper can get 2 million likes, you start to realize pharma is missing out
Drug companies still love their reps—just a lot less of them. That's the take-away from undercover observations of sales calls at primary care doctors' offices. ...
With specialty players and multiple partnerships becoming the norm, agency-client relations are being tested. Marc Iskowitz asks agency and pharma execs about what they need ...
The delectable Cipriani 42nd St. in New York was the scene for the most spectacular MM&M Awards to date. Here are some of the highlights
Jeff Tangney, Founder and CEO, Doximity
The 26th MM&M Career & Salary Survey reports that average salaries are slightly outpacing inflation. To get the whole story, download a copy of the ...
Marketing continues to be a secondary consideration in the development process
Fear is spreading faster than the illness, although this kind of meningitis is not contagious
The swirl of paper surrounding KV Pharmaceuticals' request for Chapter 11 bankruptcy protection continues to grow. At the center of the proceedings is the controversy ...
Horizon Pharmaceuticals announced in October that it has added 70 reps to its sales force as part of the Deerfield, Ill., company's push to promote ...
News on Targacept, Bristol-Myers Squibb and Merck
Med Ed Report
The number of ACCME-accredited providers has increased, from 687 to 702
Half of medical device firms responding to a recent survey said field-based medical education staffing will increase, by 10% or more, in the next two ...
By their third year of medical school, 94% of budding psychiatrists have already accepted a "small noneducational gift or lunch" from a drugmaker.
News on WedMD, Ireland's Medical Council, the Accreditation Council for Graduate Medical Education and Symbionix USA
A study published by the Proceedings of the National Academy of Science found that 43.4% of retracted articles were pulled over false and fabricated data ...
MM&M sister publication Clinical Advisor launched an app September 25 that has already captured more than 92,000 page views and almost 20,000 app launches.
News on Lippincott;s Surgical Review Library App, Health Communications and Elsevier
The use of 90-second ad units by healthcare advertisers is on the rise. Will 90s and other atypical ad-length units make TV more viable for ...
Researchers at the Colorado School of Public Health in Denver decided to see if social media influencers—a key group for marketers—can change health habits
Google's September ThinkHealth conference provided insight about what patients and physicians are looking for, and ignoring, in the webified healthcare space.
News on Everyday Health, EQAL, Healthrageous, Makovsky Health and Kelton
Sanofi Pasteur has launched its first consumer advertising for Fluzone Intradermal, featuring a prickly pitch-critter meant to stress the flu vaccine's extra-thin needle.
Stryker Medical Devices has successfully capitalized on demography and media habits with their new DTC campaign for the GetAroundKnee knee replacement.
Mylan's latest allergy awareness campaign couples two popular touch points—celebrity and access.
Novartis relaunched its advancedbreastcancercommunity.org with a focus on an often sidelined patient population—the breast cancer patients who have to live as cancer patients, not necessarily ...
Mobile health firm Voxiva, which was part of the innovative Johnson & Johnson-supported text4baby program, is looking to tackle type 2 diabetes with Care4Life.
Life science firms are starting to realize that most of the innovation unleashed by Big Data will happen through incremental, bottom-up changes rather than the ...
Software-as-a-service (SaaS) provider Appature has signed up several healthcare marketing agencies to use its cloud-based relationship marketing tool.
Neither FDA nor its HHS masters seem to know how to develop an effective regulatory scheme
A White House scientific panel has recommended that FDA expand its accelerated approval program to a broader range of drugs.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has adopted "principles" to guide interactions between companies and patient organizations.
This is how healthcare marketers engage with "consumers" every day... At times, it's downright creepy
Some critics say, in effect, "I'd rather spend $20 million on TV and get a big splash of topline revenue."
Orphan medicine is anything but me-too. But is the work?
Matt Brown, General Manager, ICC Lowe
At Work With
Ryan Mason, Vice President, Strategy & Creative, closerlook, inc.
Name That Brand
Part of a popular pharmaceutical product or advertisement, with clues to its identity.
"Big data" has radically enhanced the opportunities for industry to help patients
- Which drugmakers have the healthiest presence on social media?
- McCann Health forms new global consultancy
- Five things for pharma marketers to know: Monday, September 26, 2016
- Uber partners with startup to take patients to the doctor
- Five things for pharma marketers to know: Tuesday, September 27, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Drugmakers set their sights on the next potential blockbuster disease: NASH
- Five things for pharma marketers to know: Thursday, September 29, 2016
- BBDO picks up Neulasta; FCB gains Galderma and Sandoz work in the U.S.
- How to get more women in the C-suite, according to IPG, Unilever, and AOL
- Why Any Merger is the Last Resort of Lousy Marketers